Session date: 
Thursday, March 22, 2018 - 12:00pm to 1:00pm
Medical College of Wisconsin, Department of Pathology Administration
9200 W. Wisconsin Avenue
WDL Building, Suite 226
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

Most hospitals are not able to provide toxicology testing needed for poisoned patients or for other clinical circumstances where toxicology testing could be informative. This is because of the need for sophisticated technology, personnel, and result interpretation that is ultimately costly to the healthcare institute. The National Academy of Clinical Biochemistry (NACB) laboratory medicine practice guidelines recommend the establishment of toxicology centers supported by toxicologists and laboratory scientists that serve a community of medical centers to address this gap in patient care. Our committee is comprised of toxicologists and laboratory scientists where the goal is to gather the knowledge necessary to work towards achieving the recommendation outlined by NACB.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation:
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Target audience: 


Physicians Assistants

Allied Health Professionals

Learning objectives: 

At the conclusion of this activity, learners will be able to:

  1. Describe how Mass Spectrometry can be used to quntify specific proteins of interest without an antibody
  2. Discuss how Mass Spectrometry can be used to quntify metabodies in a multiplexed fashion
  3. Explain how Mass Spectrometry can be used to identify protein-protein interactions
Faculty & credentials: 
Planning Committee:
David Gummin, MD
Jessica Colon-Franco, PhD, DABCC
Pratistha Ranjitkar, PhD, DABCC
Sara Schreiber, MS, D-ABFT
Greg Wallace


Rebekah L. Gundry, PhD
Associate Professor of Biochemistry
Director, Center fo Biomedical Mass Spectrometry Research
Medical College of Wisconsin
All persons in control of content have NO relevant financial relationships to disclosure except:



In accordance with the ACCME® standard for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

CME Coordinator Contact Information

Shannon Majewski
Phone number: 
+1 (414) 805-6976